Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2017-04-13
2018-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Healthy volunteers :
After explaining the protocol and presenting the movement laboratory, the subjects are equipped with reflective markers on the 4 limbs, the trunk and the head. The subjects are installed on a seat positioned in front of 2 force platforms installed on the ground. The seat is equipped with a force platform.
Phase 1 :
After being seated, the subject realizes :
* 3 seat to stand and stand to seat without assistance
* 3 seat to stand and stand to seat using a handle located in front of it (handle equipped with a 6-axis force sensor)
* 3 seat to stand and stand to seat using the experimental device This phase will last 45minutes (mn) (30mn of equipment and 15mn of sitting passengers standing)
Phase 2:
After being seated, the subject performs a course comprising:
* A standing pass from sitting on a chair
* A straight line movement
* A succession of left and right turns
* An upward and downward travel of less than 1%.
* Standard doorway
* Standing on the toilet
* A sitting pass from the toilet
* One way to a bed
* A sitting pass on the bed
* A passenger seat sitting upright from the bed
* A return to the starting point
* A sitting pass on the starting chair Each stage is timed. A subjective analysis of each step is done by a lickert scale on the perceived comfort and safety.
This phase 2 will last 30mn (15mn of course and 15mn of questions).
Hemiplegic subjects :
At each session, the subject is examined by a physician who evaluates the motor control (Fugl Meyer scale), the equilibrium (Berg scale) and the spatial hemineglect (Bergego scale).
Phase 1 is performed except the 3 seat to stand and stand to seat without assistance which are impossible.
Phase 2 is performed. An evaluation of the device over 4 hours is carried out for each subject in therapeutic apartment in simulated living conditions. The validation in living lab is carried out by an ergonomist and by a questionnaire on the comfort and safety of the various steps identified by the ergonomist.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Power Assistance Device for Wheelchair-DUO
NCT03386799
Dual-task Obstacle Crossing Training in Ambulatory Subjects With Spinal Cord Injury
NCT02917590
Sit-to-stand in Spinal Cord Injury Patient
NCT02916784
Improving Clinician Capacity to Provide Interventions for Manual Wheelchair Users
NCT06294834
Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait
NCT03053791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemiplegic subjects
Testing of a new device for seated-standing passages after undergoing medical evaluation included Fugl Meyer scale, Berg scale and Bergego scale.
Phase 1 :
* 3 seated-standing passages with a handle equipped with 6 force captors
* 3 seated-standing passages with the device
New device for seated-standing passages
Phase 1 : The subject perform different seated-standing passages (see "Arm")
Phase 2 : After being seated, the subject performs a course comprising:
* A standing pass from sitting on a chair
* A straight line movement
* A succession of left and right turns
* An upward and downward travel of less than 1%.
* Standard doorway
* Standing on the toilet
* A sitting pass from the toilet
* One way to a bed
* A sitting pass on the bed
* A passenger seat sitting upright from the bed
* A return to the starting point
* A sitting pass on the starting chair
Healthy volunteers
Testing of a new device for seated-standing passages .
Phase 1 :
* 3 seated-standing passages without help
* 3 seated-standing passages with a handle equipped with 6 force captors
* 3 seated-standing passages with the device
New device for seated-standing passages
Phase 1 : The subject perform different seated-standing passages (see "Arm")
Phase 2 : After being seated, the subject performs a course comprising:
* A standing pass from sitting on a chair
* A straight line movement
* A succession of left and right turns
* An upward and downward travel of less than 1%.
* Standard doorway
* Standing on the toilet
* A sitting pass from the toilet
* One way to a bed
* A sitting pass on the bed
* A passenger seat sitting upright from the bed
* A return to the starting point
* A sitting pass on the starting chair
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
New device for seated-standing passages
Phase 1 : The subject perform different seated-standing passages (see "Arm")
Phase 2 : After being seated, the subject performs a course comprising:
* A standing pass from sitting on a chair
* A straight line movement
* A succession of left and right turns
* An upward and downward travel of less than 1%.
* Standard doorway
* Standing on the toilet
* A sitting pass from the toilet
* One way to a bed
* A sitting pass on the bed
* A passenger seat sitting upright from the bed
* A return to the starting point
* A sitting pass on the starting chair
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-75 years
* Subject having given his consent
* Free from any neurological or cardiorespiratory locomotor pathology that may interfere with standing seated passages.
Hemiplegic patients :
* Left hemiplegia in one of the following groups :
* Walking with difficulty or not walking and able to stand with a stick or an armrest
* Walking difficult or not walking and unable to stand with a cane or an armrest.
* aged 18-90 years
* Subject having given his consent
* Subjects with a trunk balance to sit without support
Exclusion Criteria
* Pain during seated-standing passages
* Unstable medical condition
* Unable to consent
* Subject under legal protection
* Left-hemineglect making standing or seated (wheelchair) displacements impossible autonomously (for hemiplegic patients)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brest University Hospital
Brest, , France
Centre de rééducation fonctionnelle de KERPAPE
Ploemeur, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC16.0012 PADH2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.